Career Updates

Aug 20, 2025, 08:31

Matt Dun: Honoured with the Australian Financial Review and UniSuper Emerging Leader Award

Matt Dun, Professor of Paediatric Haematology/Oncology Research at School of Biomedical Science and Pharmacy, shared on LinkedIn:

“I am humbled and honoured to be recognised with the The Australian Financial Review and UniSuper Higher Education Emerging Leader Award for our work researching childhood cancers.

My heartfelt gratitude to our Vice-Chancellor Alex Zelinsky for the nomination and support. University of Newcastle College of Health, Medicine and Wellbeing PVC Professor Lisa Wood for her unwavering encouragement.

This award is recognition of the hard work of my incredible DunLab team, who bring expertise, motivation, and critical thinking to tackle medicine’s greatest challenge, DIPG DMG.

I’m incredibly thankful for the backing of our charity and RUN DIPG community and of all of the other philanthropic partners that support our work. This work can’t be done without significant ongoing investment. My sincere thanks to National Health and Medical Research Council (NHMRC) and MRFF. For the first time we are seeing significant investment in projects focused developing effective treatment options for the worst of the worse.

Importantly, this award belongs to the children and families who face a childhood cancer diagnosis, and who, when all of this could be behind them, continue to stay in the fight to create change for others. Their courage, resilience and determination inspire everything we do.

My incredible family and inspirational wife for the continuous unrelenting support of this mission.

Finally, this recognition is shared with my university and medical colleagues and collaborators around the globe who are advancing this multi-national research and clinical trials. Together, we’re striving toward meaningful impact across Australia, the US, Africa and Europe.”

More posts featuring Matt Dun.

Alex Zelinsky cancer Cancer Diagnosis Childhood Cancer clinical trials Lisa Wood Matt Dun National Health and Medical Research Council NHMRC OncoDaily Oncology School of Biomedical Science and Pharmacy

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth